Concepedia

Adham Jurdi

AJ

11

Publications

471

Citations

10

H-Index

2021

Active since

Affiliations

Natera (United States)(Current)

University of California, Irvine

Cornell University

Kyushu University

Osaka University of Pharmaceutical Sciences

Adham Jurdi is an author at Natera (United States) specializing in medicine, pathology, and radiation oncology.

ORCID

Top concepts

Publications per year

2021–2024

11

Publications

11

ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa et al. · Nature Medicine · 2024 · 132 citations · Full text

, , +14

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Y.L. Verschoor, Joris van de Haar, José G. van den Berg et al. · Nature Medicine · 2024 · 93 citations · Full text

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

Brandon M. Huffman, Vasily N. Aushev, Griffin Budde et al. · JCO Precision Oncology · 2022 · 63 citations · Full text

Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.

Pashtoon Murtaza Kasi, Vasily N. Aushev, Joe Ensor et al. · Journal of Clinical Oncology · 2024 · 54 citations

, , +23

Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma

Gregory P. Botta, Maen Abdelrahim, Ronald Drengler et al. · The Oncologist · 2024 · 29 citations · Full text

Rows per page

1–5 of 11